Perbedaan Ikapharmindo Putramas Tbk. dan Solusi Bangun Indonesia Tbk.: Ikapharmindo Putramas Tbk. diperdagangkan di Rp183 (kapitalisasi pasar 313,35 M, volume 24 jam 1,41 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 22,3× kapitalisasi pasar Ikapharmindo Putramas Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IKPM | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 313,35 M | 6,99 T |
Volume | 1,41 jt | — |
Lot | 14,1 rb | — |
Perputaran | 271,25 jt | — |
Harga Rata-rata | 192,33 | — |
Nilai Transaksi | 271,25 jt | — |
Harga Ekuilibrium Indikatif | 186 | — |
Volume Ekuilibrium Indikatif | 600 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Selengkapnya di halaman IKPM →PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →